FDA inspection

Helsinn Birex Pharmaceuticals Ltd.: FDA inspection ending Sep 8, 2023

FDA inspection 1219438 · No Action Indicated (NAI) · Mulhuddart

Key facts

Inspection ID 1219438
Firm Helsinn Birex Pharmaceuticals Ltd.
FEI number 3003724414
Address Damastown Industrial Estate
City Mulhuddart
Fiscal year 2023
Inspection end date Sep 8, 2023
Classification No Action Indicated (NAI)
Project area New Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections